Gregory Scott Duncan - 23 Jun 2022 Form 4 Insider Report for Virios Therapeutics, Inc. (DWTX)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Greg Duncan
Issuer symbol
DWTX
Transactions as of
23 Jun 2022
Net transactions value
$0
Form type
4
Filing time
30 Jun 2022, 13:38:55 UTC
Previous filing
24 May 2022
Next filing
15 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIRI Stock Option (right to buy) Award $0 +90,000 $0.000000 90,000 23 Jun 2022 Common Stock 90,000 $4.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests one-third on June 23, 2023 and 1/24th monthly thereafter.